Catalyst Wire Dossier Catalyst Wire Dossier

OTIVACTO

tiotropium · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OTIVACTO, covering 2019-01-09 to 2019-09-30. Get the full timeline:

Most recent: Clinical Trial Update: OTIVACTO Spain Non Interventional Study

See pricing